SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017234
Filing Date
2017-08-10
Accepted
2017-08-10 16:05:32
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20170630.htm 10-Q 1753864
2 EX-31.1 arpo-ex311_9.htm EX-31.1 20031
3 EX-31.2 arpo-ex312_8.htm EX-31.2 21268
4 EX-32.1 arpo-ex321_6.htm EX-32.1 10512
5 EX-32.2 arpo-ex322_7.htm EX-32.2 11737
  Complete submission text file 0001564590-17-017234.txt   5723881

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20170630.xml EX-101.INS 1104165
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20170630.xsd EX-101.SCH 41233
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20170630_cal.xml EX-101.CAL 31676
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20170630_def.xml EX-101.DEF 128094
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20170630_lab.xml EX-101.LAB 337064
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20170630_pre.xml EX-101.PRE 259020
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53057 | Film No.: 171021482
SIC: 2834 Pharmaceutical Preparations